News
5th February 2026
Quadram Institute spinoff Quadlytics shortlisted for innovation award
Quadlytics, led by Dr Hannah Morelli, is developing technology that identifies combinations of bacteriophages, commonly called phages, which are helpful viruses that can be used as alternatives to antibiotics to kill bacteria in humans, animals and in the environment as well as contributing to...
View
19th January 2026
Oral bacteria play a role in chronic liver disease
Dr Naiara Beraza contributed to a new study led by the Technical University of Munich (TUM) and King’s College London that has found strong evidence that bacteria from the mouth migrate to the gut in chronic liver disease and exacerbate the disease. Each year,...
View
16th January 2026
Collapse of viral diversity in the lungs of COPD patients
This establishes bacteriophages, which are viruses that infect bacteria, as an unrecognised but potentially important component of the condition, according to a new study from the Quadram Institute, Becky Mayer Centre for Phage Research and Guangzhou Institute of Respiratory Health. Chronic obstructive pulmonary disease...
View
